.png)
We are a NTU LKCMedicine spin-off building clinically validated tools to detect cognitive decline early. Our mission is simple — give clinicians and patients the clarity they need to act before symptoms progress.

Every product we build is grounded in peer-reviewed research, not assumptions.
We publish our validation data openly. AUC 0.90, peer-reviewed, in Alzheimer's & Dementia 2026.
We measure success by patient outcomes — early detections, timely interventions, lives changed.
The researchers and clinicians behind ReCOGnAIze™ — built at NTU LKCMedicine to detect vascular cognitive impairment earlier, and more accurately.

Co-Founder & Medical Director

Co-Founder & CEO
Find a partner clinic near you or request an assessment directly. We'll confirm your booking within 24 hours.
Ready to bring cognitive screening to your patients?
Book Assessment